Hepatitis B virus (HBV) DNA is found chromosomally integrated into the genome of the majority of hepatocellular carcinomas (HCC) arising in chronic HBV carriers suggesting that, in some instances, viral sequences may be directly responsible for oncogenic conversion. In an attempt to clarify the oncogenic potential of integrated HBV sequences, we performed an extensive analysis of two single integrations present in HCC which developed in non-cirrhotic livers from HBsAg-positive Korean patients. In both cases, integrated viral sequences were characterized by a duplicated-inverted configuration involving the flanking cellular sequences, a pattern consistently found in many amplicons isolated from mammalian cells. Integration sites are characterized by an AT-rich content and the pres-
Introduction
Chronic hepatitis B virus (HBV) infection is considered to be the aetiological factor responsible for more than 75 % of hepatocellular carcinomas (HCC) reported worldwide (Nishioka, 1993) . Chromosomal aberrations are one of the prominent characteristics of tumour progression. In virusassociated tumours like HCC or cervical carcinoma, viral sequence integrations represent a specific type of host DNA lesion. HBV DNA has been consistently found integrated in the genomic sequences of the majority of HCC (for a review see Buendia, 1992) . Extensive rearrangements undergone by integrated viral sequences lead to deletion of flanking cellular Author for correspondence : Anne Dejean.
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ence of topoisomerase I and II cleavage target sequences as well as other recombination-prone motifs. The chromosomal locations of the integration sites were determined as 8q13 and 10q22 in the human genome, two regions known to harbour genes involved in tumorigenesis. The cis-activating potential of the integrations in their original configuration was also investigated in a transient transfection assay in HepG2 cells. Integrated sequences, rather than activating heterologous promoters, show either no activity or a weak tendency to inhibit activation of neighbouring reporter genes. The implications of our findings for the understanding of primary liver cancer development are discussed.
sequences, amplifications, excisions and transpositions of viral inserts, as well as chromosome translocation at the integration sites (Hatada et al., 1988 ; Tokino et al., 1991 ; Pineau et al., 1996) . Such events render the direct identification of cellular genes affected by HBV integration more difficult and so far the precise role of HBV integrations in liver carcinogenesis remains unclear.
In contrast, in an animal model, activation of the MYC gene family by insertion of woodchuck hepatitis virus (WHV) sequences nearby has been found in more than 50 % of woodchuck liver tumours analysed, supporting the hypothesis that WHV, similarly to avian or murine retroviruses, may act as an insertional mutagen. Enhanced expression of oncogenes can be detected following insertion of WHV sequences several hundred kilobases away (Fourel et al., 1994) . Furthermore, the N-myc2 promoter has been shown to be activated in vitro by WHV enhancers (Wei et al., 1992) . These findings support the hypothesis that, in human liver oncogenesis, the integration process could be accompanied by modified levels of expression of surrounding cellular genes presumably involved in the control of cell proliferation and\or differentiation Zhou et al., 1988 ; Hino et al., 1989) . Only two cases of insertional mutagenesis in human liver tumours have been reported to date (Dejean et al., 1986 ; Wang et al., 1990) .
The characterization of the outcomes of insertional recombination is a major issue for tumour virology and for gene therapy. In this study, we report the cloning and the extensive analysis of two HBV integrations showing an invertedduplicated structure that involves both virus and cellular flanking sequences, a pattern found in human and animal hepadnavirus-induced liver tumours (Hino et al., 1986 ; Zhou et al., 1988 ; Tokino et al., 1991) and frequently associated with gene amplification in mammalian cells (Ford & Fried, 1986 ; Passananti et al., 1987 ; Fried et al., 1991) . In order to better delineate the potential contribution of HBV-driven cis-activating mechanisms during human liver carcinogenesis, we also examined the impact of these integrations on a reporter gene in their ' native ' forms in a transient transfection assay in HepG2 cells.
Methods
Tumour samples. HCC and their non-tumorous liver counterparts were surgically obtained from two patients of the Yonsei University College of Medicine in Seoul (South Korea), quickly frozen in liquid nitrogen and stored at k80 mC. The tumours 5T and 7T were obtained from a 44-year-old man and a 48-year-old man, respectively. Both tumours arose on non-cirrhotic liver parenchyma. The serological markers were positive for HBsAg and negative for anti-hepatitis C virus antibody. Patients were both infected by HBV subtype adw.
DNA and RNA analyses. Genomic DNA was prepared as described previously (Hansen et al., 1993) . DNA samples (20 µg) were analysed by Southern blotting after digestion with a restriction enzyme and separation by electrophoresis on a 0n8 % agarose gel. Total RNA was isolated from tumour samples or transfected cells by a single-step method (Chomczynski & Sacchi, 1987) using the RNA-plus solution (Bioprobe) according to manufacturer's instructions ; it was subsequently treated with DNAse I to remove traces of contaminating DNA. RNA (30 µg) was analysed by Northern blot hybridization.
Southern and Northern blotting were performed according to standard methods (Ausubel et al., 1987) . Densitometric analysis of films was performed with Image Quant software (Molecular Dynamics). DNA was sequenced by the chain termination method with the Sequenase version 2.0 sequencing kit (US Biochemical). Nucleotide sequence analyses were performed using software from the University of Wisconsin Genetics Computer Group (GCG) program package (Devereux et al., 1984) .
Preparation and screening of genomic libraries. Genomic DNA (60 µg) from the tumours 5T and 7T was partially digested with Sau3AI and fractionated in a 10-40 % sucrose gradient. DNA fragments around 20 kb in size were collected and ligated in a BamHI-treated λ-GEM11 vector (Promega). Ligation products were packaged in vitro in a Gigapack Gold extract (Stratagene) and used to infect Escherichia coli LE392. The libraries (1i10' p.f.u.) were screened using total $#P-labelled HBV genome as a probe. Filters were hybridized and washed as previously reported. Phage DNA was prepared from large-scale cultures in LE392 according to standard methods (Maniatis et al., 1982) .
Probes. After purification with a Qiaex kit (Qiagen), DNA restriction fragments were radiolabelled by the random primer method with a Random-prime labelling kit (Amersham). The 645 bp RARβ (retinoic acid receptor β) probe is the fourth EcoRI restriction fragment (nt 2347-2992) from cDNA cloned by de The! et al. (1987) .
Plasmid construction and activation assay. The 8 kb HindIII-HindIII and 6 kb KpnI-KpnI fragments containing the duplicated HBV inserts and flanking sequences were isolated from clones λ5.116 and λ7.102, respectively, and subcloned into vector pKS(j) (Stratagene). These fragments were subsequently subcloned into pTK-LUC, which carries the herpes simplex virus thymidine kinase (TK) gene promoter upstream of the luciferase (LUC) gene and the SV40 polyadenylation signal (de The! et al., 1990) . Insertion of HBV integrations upstream of the TK promoter yielded constructs p5TK-LUC and p7TK-LUC. Another HBV integration (105T), described previously (Pineau et al., 1996) , contained in a SacI-BamHI 5n0 kb fragment was cloned in the TK-LUC vector to obtain the p105TK-LUC construct. Plasmids pEnh1, which contains the HBV enhancer 1 (Enh1, nt 826-1380), and pRSV-βGAL were kindly provided by G. Fourel (Institut Pasteur, Paris, France)
The human hepatoblastoma HepG2 cells were grown in Dulbecco's modified Eagle medium with 10 % foetal calf serum, antibiotics and 5 % CO # . Cells were plated 24 h before transfection. The different HBV\LUC constructs (15 µg) and the β-galactosidase expression vector pRSV-βGAL (5 µg), used as an internal control for transfection efficiency, were cotransfected in duplicate into semi-confluent HepG2 cells by the calcium phosphate precipitation method. For direct examination of RNA synthesis, 10 µg HBV plasmids were co-transfected with 5 µg carrier pKS(j) DNA per 10 cm dish. LUC activity was determined from cell extracts prepared 48 h after transfection as described previously (de The! et al., 1990) . For each construct, three independent experiments were performed and results were normalized for transfection efficiency by reference to β-galactosidase activities. Activation is expressed on histograms as the ratio of the level of luciferase activity directed by the indicated construct to that directed by the TK promoter alone.
In situ fluorescence hybridization. Metaphase spreads were prepared from phytohaemagglutinin-stimulated human lymphocytes, cultured at 37 mC for 72 h. 5-Bromodeoxyuridine was added for the final 7 h of growth (60 µg per ml of medium) to ensure a chromosomal Rbanding of good quality. The λ5.116 and λ7.105 phages containing an insert of 16-17 kb were biotinylated by nick translation with biotin-16-UTP, as outlined by the Boehringer Mannheim protocol. Hybridization to chromosome spreads was performed by a standard protocol (Pinkel et al., 1986) ; for each slide, 400 or 500 ng biotinylated DNA was used. Before hybridization, the labelled probe was annealed with a 150-fold excess amount of Cot-1 DNA (GIBCO-BRL) for 45 min at 37 mC in order to compete with the aspecific repetitive sequences. The hybridized probe was detected with fluorescence isothiocyanate-conjugated avidin (Vector laboratories). Chromosomes were counterstained and R-banded with propidium iodide diluted in antifade solution (pH 11) as described previously (Lemieux et al., 1992) .
Results

Structural organization of integrated HBV DNA
Genomic DNA was extracted from HCC samples as well as the adjacent non-cirrhotic livers from six male patients living in Korea. Of the samples analysed by Southern blotting, two of them, tumours 5T and 7T, exhibited a single 8 kb hybridizing fragment after HindIII digestion corresponding to a unique HBV integration (Fig. 1 ). In the two patients from whom these samples came, no free viral genome DNA was detected in the tumorous or non-tumorous samples.
To investigate the possible causal relationship between HBV DNA integration and subsequent tumour development in the two non-cirrhotic livers, we decided to further characterize the structure of integrated viral DNA in tumours 5T and 7T. Four (λ5.82, λ5.83, λ5.101, λ5.116) and two (λ7.102, λ7.105) independent HBV-hybridizing clones were obtained from genomic libraries 5T and 7T, respectively. Restriction maps of the 20 and 20n5 kb genomic loci covered by the four 5T and the two 7T overlapping clones, respectively, are shown in Fig. 2 . Based on both the restriction maps and the nucleotide sequence analysis, integrated HBV DNA was found to be of the adw subtype in the two patients (Valenzuela et al., 1979) . Large inverted repeated structures consisting of portions of the HBV genome along with flanking cellular sequences were present in the rearranged alleles of the 5T and 7T genomes (Fig. 2) . To more precisely analyse the organization of integrated viral DNA, an 8 kb HindIII and a 6 kb KpnI fragment encompassing the whole HBV sequence were subcloned from phages λ5.116 and λ7.102, respectively, and subjected to further nucleotide sequence analysis.
In tumour 5T, integrated HBV DNA consisted of two DNA segments of 1n5 and 3 kb linked in an inverted and partially duplicated fashion (Fig. 2 b) . The shorter fragment began in the preS2 domain (nt 60) and ended up in the cohesive-end region at position 1614, a few bp downstream of the second direct repeat (DR2, nt 1592-1602) (Fig. 2 b) (Dejean et al., 1984) . The larger fragment covered the virus genome from nt 1825, 1 bp away from the first direct repeat (DR1) motif (nt 1826-1836), to nt 1614 (the same as the shorter fragment). Regarding the orientation of virus transcription, the two segments were found to be tail-to-tail. The inverted duplication extended to the flanking cellular sequences for a distance of at least 5 kb (Fig. 2 a) .
Clones from tumour 7T (Fig. 2 c) harboured a similar structure containing 5n4 kb of integrated HBV DNA composed of two fragments of 3n2 and 2n2 kb (Fig. 2 d) . The larger fragment consisted of an almost complete virus genome extending from the 5h coding region of the initiation ATG codon of the X gene (nt 1388) to nt 1366, 10 bp upstream of the X gene ATG. The smaller fragment started within the core region (nt 2390) and ended up at the same virus-cell junction as that observed for the larger segment (nt 1366). The duplicated region also involved a minimum of 3n5 kb of adjacent cellular sequences.
Comparison of HBV DNA sequences present at the virus-virus junctions in each of the two loci revealed short patches of homology (data not shown). At the 5T virus-virus junction, four out of seven nucleotides were identical while at the 7T virus-virus junction a slightly stronger homology was noted with seven out of ten common nucleotides. Such short homologies are thought to have some impact on illegitimate recombination mechanisms by allowing the initial positioning of the two DNA strands.
Overall, HBV integrations in tumours 5T and 7T harbour a general pattern of inverted duplications with an asymmetric non-duplicated portion found at the centre of the duplication (Ford & Fried, 1986 ; Hyrien et al., 1988) .
Integration sites
To determine whether the viral genome integrates in close proximity to a putative cellular gene, we looked for cellular DNA devoid of repetitive sequences in the vicinity of the integrations. Hybridization with $#P-labelled human genomic DNA resulted in strong hybridization signals indicating that, in both 5T and 7T, the HBV genome integrated within regions enriched in repetitive elements (shaded boxes in Fig. 2 a, c) .
At the tumour 5T integration site, we were able to identify a 2n0 kb KpnI-HindIII fragment (referred to as KH2.0 in Fig.  2 a) , which showed no hybridization with human repetitive DNA and was located 1n5 kb away from the virus integration site. When used as a probe during Southern blot analysis of HindIII-digested tumorous and non-tumorous DNA from patient 5, a single hybridizing band was detected in both samples (Fig. 3 a) . An estimated quantification of the KH2.0 hybridizing band in the T lane compared with that in the N lane with respect to an internal control (RARβ probe) revealed the same value suggesting that duplication of one allele is associated with deletion of the other (data not shown).
Similarly, we analysed the integration site of tumour 7T and isolated a HindIII-XhoI DNA fragment of 3 kb (HX3.0 on Fig. 2 c) located 10 kb away from the HBV sequences. On a Southern blot from patient 7, the HX3.0 fragment, used as a probe, revealed a unique band with a weak smear (Fig. 3 b) . Densitometric analysis of the HX3.0 hybridizing band in the tumour lane revealed that the signal was 1n5 times that of the non-tumorous sample with respect to the internal RARβ control suggesting the presence of three copies in the 7T tumorous sample.
Northern blot analysis of poly(A) RNA isolated from the tumorous and non-tumorous regions of samples 5T and 7T using probes KH2.0 and HX3.0, respectively, did not reveal any significant signals suggesting that these sequences are either not transcribed or transcribed at a very low level (data not shown).
We determined the sequences of the 1190 and 1335 nt of genomic DNA immediately flanking the integrated viral sequences in 5T and 7T, respectively (EMBL accession numbers of the sequences are AJ000498 and AJ000499, respectively).
Screening of databases for each of the two sequences did not reveal any similarity to known genes. We used several simple analyses to investigate the potential role that the sequence structure of the cellular DNA may play in the position of HBV integration. Both cellular integration sites were AT-rich regions with 68 and 73 % AT in 5T and 7T, respectively. Such composition is usually considered to be a preferential target for virus or transposable element integrations (Zambryski, 1988 ; Passananti et al., 1987 ; Fried et al., 1991 ; Kahn et al., 1994) . It has been shown recently that DNA integration occurs preferentially in unstable regions (Rassool et al., 1991 ; Merrihew et al., 1996) . Using the Findpatterns searching tool of the Wisconsin GCG package, we also looked for short sequence motifs that have been implicated in recombination, including chi-like sequences, immunoglobulin heptamers, alpha protein recognition sites, the consensus topoisomerase I and II recognition sites, three hypervariable minisatellite sequences and consensus common hotspots for gene deletions and translocations (Kahn et al., 1994 ; Cullen et al., 1995 ; Wilke et al., 1996) . At each integration site we were able to detect one alpha protein recognition sequence, a heptanucleotide motif which should occur only once every 16384 bases. In addition, one topoisomerase II site, a 2-to 3-fold excess of topoisomerase I cleavage sites (5h C\GTT 3h) and a 1n5-to 2-fold excess of deletion\translocation-related consensus sequences were present in both flanking sequences. The over-representation of such recombination-prone motifs suggests that both viruses integrated in potentially unstable genomic regions. We were interested in mapping the two HBV integration sites in the human genome. To do this, phages λ5.116 and λ7.102 were used as probes for in situ hybridization. The great majority of the fluorescent spots were concentrated on the 10q22.1 and 8q13 bands of the human genome (Fig. 4) . These data indicate that HBV integrated in a region corresponding to the q22.1 band of chromosome 10 in patient 5 and to the q13 band of chromosome 8 in patient 7.
Cis-activity of integrated virus sequences
Cis-activity of integrated HBV sequences has been suspected in some instances to play a part in the tumorigenic process Zhou et al., 1988 ; Hino et al., 1989) . The high prevalence of duplicated-inverted HBV integrated sequences in HCC evokes the situation described for feline leukaemia virus-induced tumours in which it has been shown that repeated integrated sequences behave as strong enhancers (Athas et al., 1995) . Mapping studies have demonstrated the existence of two enhancers, Enh1 (nt 965-1235) and Enh2 (nt 1635-1745), within the HBV genome. To determine whether duplicated HBV integrations that contain at least one of the two enhancer regions are endowed with cisactivating potential, we inserted integrations cloned from tumours 5T and 7T, as well as from tumour 105T, a previously reported HCC case (Pineau et al., 1996) , in front of a TK promoter-LUC reporter gene construct and we tested the different vectors by transient transfection assay in HepG2 cells.
Unexpectedly, none of the three integrations tested (Fig. 5 , constructs 3, 4 and 5) exhibited significant enhancer activity when compared to the parental TK-LUC vector alone (construct 1). However, virus sequences in constructs 3 and 5 conferred a 2-and 3-fold repressing activity, respectively. Under the same conditions the 554 bp fragment corresponding to Enh1 (construct 2) induced a 12-fold increase in LUC activity, which is comparable to that obtained in previous work (Wei et al., 1992) . Nucleotide sequence analysis of the enhancer elements present in tumour 5T and 7T integrations revealed only minor changes compared to the original Enh1 and Enh2 sequences (Galibert et al., 1979 ; Valenzuela et al., 1979) . Moreover, these mutations have already been described in variant viruses (Norder et al., 1993) . It is therefore doubtful that such mutations could abrogate the activating capacity of the enhancer sequences. Another possible explanation for the differences observed between the enhancer properties of HBV integrations reported previously and our data is the use here of full-length ' native ' integrations containing enhancer elements in their original context whereas other workers used only minimal subgenomic regulatory sequences (Wei et al., 1992 ; Fourel et al., 1992 Fourel et al., , 1996 Ueda et al., 1996) .
Discussion
In this report, we describe the structure, chromosomal localization and cis-activating potential of HBV integrations in two HCC arising on non-cirrhotic livers. We found that, in both cases, the integrated virus sequences showed an invertedduplicated organization involving host flanking DNA. Inverted duplications are usually a rare event in the DNA tumour virus integration process (Lawrence et al., 1988 ; Hurley et al., 1991) . They are, however, a common feature in hepadnaviral integrations. A high prevalence of such integration patterns has also been observed in the majority of integrants of Agrobacterium tumefaciens T-DNA, a transposon causing neoplastic diseases in dicotyledonous plants (Zambryski, 1988) . The fact that both the T-DNA and part of the HBV genome are single-stranded may not be inconsistent with both their ability to ' invade ' target genomic sequences and the structure of their integrated forms (Gheysen et al., 1987) .
In mammalian cells, head-to-head or tail-to-tail inverted duplication arrays are a common trait of amplified regions and it has been suggested that the formation of such inversions constitutes the initial step leading to genomic instability involving both amplification and deletion processes (Ford & Fried, 1986) . These structures form hairpins or stem-loop structures which are excised from their templates and constitute the precursors for circular inverted dimers often observed during gene amplification (Ruiz & Wahl, 1988 ; Fried et al., 1991) . Alternatively, a study of transgenic mice has recently shown that the inverted repeat region can promote deletions extending into the DNA flanking the transgene (Collick et al., 1996) . In the case of tumours 5T and 7T, it is quite clear that the viral duplicated inversions that involve flanking cellular sequences are produced only after integration of HBV DNA into the host chromosome. These oligomeric forms of HBV may possess the capacity to be excised and transposed within the human genome, as suggested previously (Ziemer et al., 1985) . However, they are unable to further generate expanded chromosomal regions. This might be due to their lack of a functional DNA replication origin (Nonet et al., 1993) and\or the absence of cellular factors responsible for the amplification process in hepatocytes (Cohen et al., 1994) . An important issue to consider is why HBV sequences are particularly prone to adopt an inverted-duplicated configuration in vivo as similar structures are almost never identified with other DNA tumour viruses. One can formulate several hypotheses to explain this unique phenomenon : (i) some specific traits of the primary or secondary structure of the HBV genome permit integrated DNA to evolve toward a duplicated structure endowed with a unique stability ; (ii) the repair process at a target site may lead integrated and flanking sequences to adopt such a specific pattern ; and (iii) functional properties associated with inverted duplications may confer a selective advantage if either enhancers need to be present in duplicate or duplication is required to maintain a specific chromatin configuration necessary to influence some critical gene expression (Gubbay et al., 1992) . A functional role for inverted-duplicated sequences is indicated by the fact that such sequences encoding drug-resistance genes are readily lost in cell culture in the absence of drug selection (Ruiz & Wahl, 1988) .
Examination of virus-cell or virus-virus breakpoints in HBV integrations reported so far in the literature reveals that they are not evenly distributed along the virus genome suggesting the existence of a non-random mechanism of integration (Fig. 6) . Insertion of HBV sequences into the host DNA is frequently characterized by disruption of the viral genome at the cohesive-end region (nt 1602-1836) and even more consistently in the vicinity of DR1 (Fig. 6) . The region encompassing nt 1600-2000 reaches a recombination site density almost 5-fold higher than the remaining part of the genome. In this respect, it is noteworthy that three out of the four viral junctions present in tumour 5T integration lie within the cohesive-end region. Cellular sequences flanking the two viral integrations contain many illegitimate recombination-prone motifs such as topoisomerase I and II cleavage sites, deletion\translocation-related consensus sequences or alpha protein recognition sequences. Thus, these host DNA sequences represent two particularly suitable cellular targets for virus integration.
Enhancer elements are frequently associated with viral genomes. They function in an orientation-independent manner sometimes over considerable distance (Lazo et al., 1990) . The flexibility in their interaction with promoter elements raises the possibility of improper activation of cellular genes by transposed enhancers. Some of them, particularly the simian virus 40 (SV40) enhancer, are able to activate promoters of a variety of genes. The woodchuck model has shown that insertion of WHV enhancers I and II can up-regulate the N-myc gene promoter in vivo and in transient transfection assays (Wei et al., 1992) . Moreover it has been suggested that, in WHV-induced tumours, viral sequence activity is able to stimulate transcription over a distance of several hundred kilobases (Fourel et al., 1994) . Our experiments indicate that, in contrast to previous findings, integrated HBV sequences rather than activating heterologous promoters show either no activity or a weak tendency to inhibit activation of neighbouring reporter genes. This discrepancy could be partly explained by the fact that, so far, only selected parts of the viral genome have been used in transient transfection studies, whereas, in the present study, we used full-length integrations in activation assays (Wei et al., 1992 ; Fourel et al., 1992 Fourel et al., , 1996 Ueda et al., 1996) . A second hypothesis for this lack of function may be that the juxtaposition of several regulatory elements caused by rearranged integrations in tumours 5T, 7T and 105T could result in an enhancer occlusion analogous to that observed with the FJH SV40 enhancer or the avian leukosis virus long terminal repeat in certain circumstances (Kadesh & Berg, 1986 ; Cullen et al., 1984) . Another possibility may be that the point mutations observed in the enhancer regions of the virus integrations affect the binding of transcriptional activators. Finally, our experiments using an in vitro model system may be only distantly related to the situation prevailing in vivo where enhancer activity is highly site-dependent (Walters et al., 1996) .
We mapped the HBV integration sites from tumours 7T and 5T in chromosomes 8q13 and 10q22.1, respectively. No specific translocation breakpoints have been mapped in these two chromosomal regions. However, fragile sites FRA8F and FRA10D are present in 8q13 and 10q22.1 (Genome Database, 1997) . So far, no HBV integration has been described on 8q or 10q but both chromosomal arms are considered as preferential regions of integration for human papillomaviruses (Couturier et al., 1991 ; Du$ rst et al., 1987 ; Kahn et al., 1994) . A putative protooncogene, Lyn, and a tumour suppressor gene, PTEN\ MMAC1, have been described in 8q13 and 10q23, respectively (Yamanashi et al., 1987 ; Li et al., 1997) . Other genes that may play a role in cell proliferation are located at these cytogenetic locations : the genes encoding the telomeric repeat binding factor (TRF1), the cAMP phosphodiesterase 7A (PDE7A) and the GTP-binding mitogen-induced protein (GEM) were mapped in 8q13 and the genes encoding the dimerization co-factor of hepatocyte nuclear factor 1 (DCOH) and vinculin (Genome Database, 1997) are located in 10q22.
The liver plays a central role in the pathophysiology of many genetic and infectious diseases. It is therefore an important organ for targeted gene therapy . Recent developments suggest that stable integration of virus vectors will provide the necessary long-lasting expression of therapeutic genes in the future (Overturf et al., 1996) . Thus, to overcome the risk associated with therapeutic utilization of virus vectors, the characterization of virus integrations is of great importance for a better understanding of the integration mechanism, chromatin organization and stable gene expression in the liver.
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